In vivo imaging of murine endocrine islets of Langerhans with extended-focus optical coherence microscopy by Villiger, M. et al.
ARTICLE
In vivo imaging of murine endocrine islets of Langerhans
with extended-focus optical coherence microscopy
M. Villiger & J. Goulley & M. Friedrich &
A. Grapin-Botton & P. Meda & T. Lasser & R. A. Leitgeb
Received: 19 December 2008 /Accepted: 8 April 2009 /Published online: 30 May 2009
# Springer-Verlag 2009
Abstract
Aims/hypothesis Structural and functional imaging of the
islets of Langerhans and the insulin-secreting beta cells
represents a significant challenge and a long-lasting
objective in diabetes research. In vivo microscopy offers a
valuable insight into beta cell function but has severe
limitations regarding sample labelling, imaging speed and
depth, and was primarily performed on isolated islets lacking
native innervations and vascularisation. This article introduces
extended-focus optical coherence microscopy (xfOCM) to
image murine pancreatic islets in their natural environment in
situ, i.e. in vivo and in a label-free condition.
Methods Ex vivo measurements on excised pancreases
were performed and validated by standard immunohisto-
chemistry to investigate the structures that can be observed
with xfOCM. The influence of streptozotocin on the
signature of the islets was investigated in a second step.
Finally, xfOCM was applied to make measurements of the
murine pancreas in situ and in vivo.
Results xfOCM circumvents the fundamental physical limit
that trades lateral resolution for depth of field, and achieves
fast volumetric imaging with high resolution in all three
dimensions. It allows label-free visualisation of pancreatic
lobules, ducts, blood vessels and individual islets of Langer-
hans ex vivo and in vivo, and detects streptozotocin-induced
islet destruction.
Conclusions/interpretation Our results demonstrate the
potential value of xfOCM in high-resolution in vivo studies
to assess islet structure and function in animal models of
diabetes, aiming towards its use in longitudinal studies of
diabetes progression and islet transplants.
Keywords Mouse . Imaging . Islets
Abbreviations
MRI Magnetic resonance imaging
NA Numerical aperture
OCM Optical coherence microscopy
OCT Optical coherence tomography
OPT Optical projection tomography
PET Positron emission tomography
xfOCM Extended-focus optical coherence microscopy
It is essential to be able to measure the structure and
function of individual islets of Langerhans [1]. To further
the understanding of the mechanisms of diabetes and to
evaluate treatments of the disease, monitoring of functional
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islet variables is mandatory. Most applicable to a clinical
setting are positron emission tomography (PET) and
magnetic resonance imaging (MRI) [2–4]. Their medical
potential is undoubted but, to date, only optical methods
have provided the necessary spatial resolution to resolve
individual islets [5]. Although most of these methods are
likely to have little impact on clinical practice and human in
vivo imaging, they are indispensable and complementary
tools to provide insight into the cellular and molecular
mechanisms of this disease.
The preparation of sections with immunocytochemical
labelling is the standard method to visualise subcellular
structures and to discriminate between the various islet cell
types. This method is time consuming and only gives a
two-dimensional view of the tissue slices. Optical projec-
tion tomography (OPT) [6] has been used to image the
adult mouse pancreas and to retrieve the three-dimensional
and undistorted structure of the tissue, which may be
quantified. However, such approaches require sample
fixation and immunolabelling and, hence, cannot be applied
in vivo [7, 8].
Likewise, functional studies are performed in vitro on
isolated islets [9, 10] and often after fluorochrome labelling,
which is prone to bleaching and phototoxicity. Two-photon
microscopy reduces these effects [11]. Even so, the islets
are deprived of their natural tissue environment which
limits the physiological relevance of such studies.
In recent work [12] islets have been transplanted into the
mouse eye. Engrafted on the iris they could be repeatedly
imaged using the eye as a natural body window. This
minimally invasive approach allows longitudinal monitor-
ing of individual islets and visualisation of islet vascular-
isation, beta cell function and death by using two-photon
fluorescence microscopy in combination with appropriate
fluorochromes and transgenic mouse models expressing
green fluorescent protein.
Here, we report on the first three-dimensional in vivo
imaging of the murine pancreas macro- and microstructure
by an approach that requires no labelling and that works in
situ. The islets are studied in their natural environment with
their native innervation and vascularisation. The technique
we have developed is extended-focus Fourier domain
optical coherence microscopy (xfOCM) [13]. It is based
on optical coherence tomography (OCT), an emerging
biomedical imaging modality that provides cross-sectional
views of the subsurface microstructure of biological tissue
[14, 15]. It employs light from a low coherence source that
is back-scattered by differences in the tissue refractive
index and that is combined with a strong reference signal.
The detection in the Fourier, or frequency, domain
spectrally separates the interference signal into its chromat-
ic components and records the resulting pattern with a line
camera. Processing of this pattern extracts the sample
structure along the axial direction in parallel without axial
scanning and with a high resolution of 2–3 μm [16].
Together with its high sensitivity [17] that allows imaging
several hundred micrometres into the tissue, Fourier
domain OCT provides an exceptional speed advantage over
other optical imaging methods, making it a confirmed tool
for comprehensive volumetric imaging [18, 19].
Classic optical coherence microscopy (OCM) [20, 21]
uses standard focusing optics to obtain high lateral
resolution. The resulting short depth of field hampers the
parallel depth extraction of Fourier domain OCT and
necessitates time-consuming scanning in all three dimen-
sions, which makes in vivo measurements difficult. Our
novel approach has been to circumvent this compromise
between lateral resolution and depth of field by engineering
an extended focus that is scanned rapidly in the lateral
directions.
Our study validates this approach for the in vitro and in
vivo imaging of islets of Langerhans and provides evidence
for its potential value in structural and functional studies.
Methods
xfOCM setup The prototype xfOCM system developed for
this study provides a high, near isotropic resolution of
1.3 μm in the lateral and 2 μm in the axial direction,
revealing structural details and fine cell arrangements over
an axial range of 300 μm. The basic layout is displayed in
Fig. 1. The linearly polarised light source (Ti:Sapphire
laser, Femtolasers, Vienna, Austria; central wavelength: 780
nm; spectral full width at half maximum: 130 nm) is
collimated (LS: f=8.2 mm) and split by the beamsplitter
BS1 into sample and reference arm (Fig. 1). The sample
beam passes through the axicon (apex angle 180° – 2β=
175°) and is relayed (LR: f=100 mm) through the scanning
system, which provides rapid lateral scanning. The two
galvo scanners rotate the beam around a common pivot
point and the lens LT (f=164 mm) creates finally a thin
annulus of radius ≈ fβ(n–1) in the back aperture of the
objective (Zeiss Neofluar, ×10, numerical aperture [NA]
0.3; Carl Zeiss, Jena, Germany). The common pivot point
of the scanning system, in a conjugate plane of the back
aperture of the objective, is crucial to the correct scanning
of the beam in the lateral directions. In the sample region,
the different contributions converge in the proximity of the
focal plane and interfere to create a Bessel-like illumination
pattern in the radial direction, propagating nearly diffraction
free over a long axial distance of nearly 400 μm with a
uniform lateral definition of ∼1.3 μm (see small inlet in
Fig. 1). The light back-scattered from the sample is
decoupled from the illumination path by beamsplitter BS2
to prevent a double pass through the axicon. The descanned
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signal is combined with the reference beam and coupled
into the detection fibre of NA 0.12.
This detection scheme has a twofold impact. First, the
signal is detected with high efficiency, resulting in
sufficient sensitivity to image biological samples. Second,
with the detection aperture smaller than the annulus
diameter, light from specular reflection is suppressed,
producing a dark field effect. Nevertheless, the resulting
detection volume acts as apodisation on the illumination
needle, producing an effective extended focus of ∼300 μm.
The signal is analysed with a spectrometer consisting
of a transmission grating (1,200 lines/mm) and a linear
camera with 2,048 pixels (Atmel Aviva, Stemmer Imag-
ing, Pfäffikon, Switzerland) set to an integration time of
40 μs, working at a depth profile rate of 20 kHz. The
illumination power on the sample was 3–4 mW. Adjacent
scanning points were separated by between 0.2 μm and
2.5 μm, varying the area of one scan between 100×200 μm
and 2×1.2 mm.
Signal processing The signal recorded on the spectrometer can
be expressed as ,
where Ar and As are the amplitudes of the electromagnetic
field in the reference and sample arms, respectively, h(z)
represents the local reflectivity of the sample structure
as a function of z, k=2π/λ is the wave number, and
a2 ¼ R h zð Þei2k zz0ð Þdz 2 is the total reflectivity of the
sample. To reconstruct the sample structure, we compute
the Fourier transformation of the signal after subtracting
the average spectral background and performing an
interpolation to a linear k-space. The signal processing
was performed on a 2.13 GHz dual core Intel Xeon based
personal computer with 4 GB DDRII SDRAM. The
Microsoft Windows XP-based application software was
developed in C++ and made use of the Trolltech QT v4.3
framework (Trolltech, Oslo, Norway; www.trolltech.com/,
accessed 4 May 2007), the GNU Scientific Library v1.8
(Free Software Foundation, Boston, MA, USA; www.gnu.
org/software/gsl/, accessed 18 May 2007) and the Fastest
Fourier Transform in the West (FFTW) v3.1.2 library
(Massachusetts Institute of Technology, Boston, MA,
USA; www.fftw.org/, accessed 5 June 2007).
All figures display the logarithm of the squared signals,
and are rescaled and adjusted to optimise contrast and
brightness. The z-axes of the tomograms were rescaled by
an estimated sample index of n=1.33 in order to represent
geometrical distances rather than optical path lengths. Apart
from the in vivo images, for which an image registration
was performed, no post processing was applied. Figures 2d
and 3a were produced using Voxx, a freeware three-
dimensional rendering program (www.nephrology.iupui.
edu/imaging/voxx, accessed 4 November 2008). Electronic
supplementary material (ESM) videos 3 and 4 were ren-
dered with Imaris (Bitplane, Zürich, Switzerland).
Semi-automatic islet detection In order to perform statisti-
cal analysis, the tomograms were screened for islet-like
structures. Determination of the islet volume and position
was achieved by manually defining a region of interest and
automatic extraction of the precise islet shape by filtering
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Fig. 1 Principle layout of the xfOCM setup. The incoming broadband
light is collimated by lens LS and split by beamsplitter BS1 into
sample and reference beam. The light in the sample arm passes
through the axicon, is relayed by lenses LR through the scanning
system and focused by lens LT into a thin annulus in the objective’s
aperture (small inlet). In the sample region, interference produces a
light-needle which extends over a long axial range T (big inlet),
scanning the sample in the lateral directions. The backscattered light is
recombined with the light from the reference arm at beamsplitter BS2
and coupled into the detection fibre by lens LD. The detected
interference pattern is corrected by the reference spectrum and fast
Fourier transformed (FFT) from the wave-number k-space to the axial
coordinate of the sample structure
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and thresholding (see ESM 1). The volumetric islet mask
obtained was used to estimate the mean of the islet signal.
Likewise, the mean of the signal from the exocrine tissue
surrounding the islet was extracted. The difference of these
two values gives a measure of the contrast of an islet. In a
further step, the signal variation within the islet core was
analysed to evaluate homogeneity, expressed as the lateral
gradient of the mean signal in function of depth within the
islet, going from the outer surface to its inner core.
Preparation of dissected pancreas All animal studies were
approved by the Cantonal Veterinary Office (Vaud, Switzer-
land) and were conducted in accordance with Swiss animal
protection law.
Pancreases (n=13) from 3-month-old ICR female mice
(Harlan Laboratories, Itingen, Switzerland) kept in normal
housing and with food ad libidum (2018 Teklad Global
18% Protein Rodent Diet, Harlan Laboratories) were
dissected. The samples were fixed for 45 min in a 4%
(vol./vol.) paraformaldehyde solution in PBS at room
temperature, prior to an overnight incubation in a 30%
(wt/vol.) sucrose solution in PBS at 4°C. The samples were
placed on a coverslip, on top of humidified filter paper, in
order to avoid dehydration. Different regions were pre-
sented to the objective to obtain an overview of the
pancreatic organ structures.
Immunohistochemistry Three samples studied by xfOCM
were embedded in Tissue-Tek OCT and frozen at −80°C.
Sections of 8 μm thickness were prepared, washed in PBS
and blocked with PBS and 10% FCS for 30 min at room
temperature. Primary antibodies (directed towards: insulin,
diluted 1 to 100 [Linco, St Charles, MO, USA]; lectin
dolichos biflorus agglutinin (DBA), diluted 1 to 500
[Vector Laboratories, Peterborough, UK]; CD31/ platelet/
endothelial cell adhesion molecule-1, diluted 1 to 50 [BD
Biosciences, Allschwil, Switzerland]) were diluted in TBST
(Tris-buffered saline and 0.2% [vol./vol.] Triton X-100)
containing 10% (vol./vol.) FCS, and incubated with the
sections overnight at 4°C. Sections were washed in PBS,
incubated for 1 h with secondary antibodies (Alexa 405,
488 and 555; Invitrogen, Basel, Switzerland) diluted in
TBST containing 10% (vol./vol.) FCS, washed in PBS and
mounted. The sections were analysed using a Leica DM
5500 with a ×10 objective, using excitation wavelengths
adapted to each fluorochrome.
Sample preparation from mice injected with streptozotocin
C57B6 male mice were controlled for normoglycaemia and
then injected once i.p. with either 0.22 mg/g of freshly pre-
pared streptozotocin (Sigma Chemicals, St Louis, MO, USA)
or the corresponding volume (15 μl/g) of the 0.1 mmol/l
citrate buffer (pH 4.5) that was used to dissolve the drug.
Thereafter, blood glucose levels of all animals were evaluated
every 3 days using a Glucocheck [22].
The animals were killed 4–7 days after the streptozotocin
injection and the pancreases were rapidly sampled, weighed
and cut into two pieces. One piece was immediately
extracted in 5 ml acid ethanol for evaluation of insulin
content, as determined by a radioimmunoassay [22]. The
other piece was fixed for xfOCM under double-blind
conditions.
For xfOCM, the samples were mounted between a
coverslip and sample holder, by means of a plastic spacer
of 1 mm thickness. For each sample four regions, each of
1×1.5 mm, were randomly chosen and scanned. The
resulting tomogram stacks were then inspected to semi-
automatically detect and classify the islets (ESM video 1
shows the overview of all measured samples).
In vivo experiment Adult ICR mice (n=5) (Harlan Labora-
tories) were anaesthetised with i. p. injection of a solution
of 14.5 mg/kg Rompun (Bayer, Zürich, Switzerland) and
90 mg/kg kétasol 100 (Dr E. Graeub AG, Bern, Switzer-
land). The flank skin was shaved and cleaned with Betadine
swab. An incision of 0.5–1 cm was made through the
abdominal muscles to gently pull out the duodenum
Fig. 2 Scanning principle of xfOCM. a Scanning along one lateral
direction creates a tomogram along the depth and the scan axis (green
rectangle). Acquiring many such tomograms by scanning along the
second lateral direction provides a three-dimensional volume (blue
cube). En face images can be generated by selecting one depth (red
rectangle). The pancreas consists of the head (h) and the tail (t),
connected by the neck (n). b Lateral scan of a fixed sample, measured in
the neck region depicting a 1 mm×0.65 mm field (scale bar, 250 μm).
Two small islets are present (arrows), along with vessel structures
(dashed arrows). The bright line at the top of the tomogram indicates the
sample surface that strongly reflects the incident light. c En face image
at a depth of 220 μm showing five islets (arrows) and vessels (dashed
arrows) (scale bar, 250 μm). d The volume data can be represented with
a three-dimensional rendering, giving a three dimensional impression
(1.5×1×0.65 mm). See also ESM videos 1 and 2 for the complete
volume data and a three-dimensional rendering
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encircling the head of the pancreas. The duodenum was
stabilised around a pillar during the scanning procedure.
The mouse was exposed to a heating lamp and both
pancreas and intestine sprayed with 0.9% NaCl during the
procedure. The measurement was completed and the
incision sutured within 30 min of the start of the operation.
Statistical analysis Results are expressed as means ± SE.
Differences in the mean values of blood glucose and insulin
content were tested by analysis of variance using the SPSS
program (SPSS, Chicago, IL, USA). Student’s t tests with
unequal variances were performed to determine the differ-
ences in the means of islet contrast and homogeneity.
Results
Ex vivo imaging of pancreas To investigate the contrast and
the structures which can be observed with xfOCM, we excised
and fixed the whole pancreases of adult wild-type mice and
placed them on microscope slides. The optical setup was
mounted on a table in the horizontal direction and the sample
was accessed from the side, as indicated in Fig. 2a. The
pancreas can be segmented into a tail or splenic part attached
to the spleen and a head encircled by the duodenum,
connected by a thin neck. Figure 2b shows the tomogram
of a scan of the neck of a pancreas. Two islets of Langerhans
of different sizes are clearly visible as spherical structures
with high contrast. The xfOCM signal arises from light
scattered by tissue discontinuities. The exocrine tissue has a
more granular structure and scatters less light, whereas the
ducts and vascular networks appear as dark regions with
only their epithelial walls scattering incident light. Adjacent
lateral scans were assembled to produce en face images
(Fig. 2c), and to generate three-dimensional renderings of the
whole volume data, allowing determination of the spatial
position and the shape of the islets (Fig. 2d). ESM videos 2
and 3 show, respectively, en face scans at increasing depths
and a three-dimensional rendering of the same volume data.
The semi-automatic islet detection helped to exploit this
volumetric information and determine the amount of islets
and their volume. Four regions of 1.5×1 mm each were
scanned for three different animals. Figure 3a depicts all
Fig. 3 a Size distribution of the islets in linear scale (n=3, 3 mm3 per
animal analysed). b The same data as in (a) but on a logarithmic scale,
where each size category is four times the volume of the previous one,
demonstrating the resolving power of xfOCM. c Depth distribution of
the detected islets. Close to the surface, the pancreas has less islets
than in the deeper lying tissue. The reduced number of islets for bigger
depths points out the detection limits of the method. d Islets of
different sizes and at different sample depths. Each islet is shown with
a en face view (top row) and a lateral scan (bottom row). The depth
categories indicate that the islets were found within the first 200 μm
(large), between 200 μm and 400 μm (medium), and beyond 400 μm
(small) in the tissue, respectively. At increasing depth, the lateral
resolution is blurred. Scale bar, 100 μm
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146 islets distributed into different depth categories.
Despite the scattering of the pancreatic tissue, which
disturbs the propagation of the incident beam to deeper
lying structures and ultimately limits the imaging depth, we
could image islets up to more than 500 μm in diameter. The
histogram of linearly increasing size categories (Fig. 3b)
shows that while many small islets were found, only a few
larger islets were detected. The same data, but in a
logarithmic scale, are displayed in Fig. 3c. Islets down to
a size of only about 15 μm in diameter (∼2000 μm3),
corresponding to an aggregate of only a few cells, were
reliably detected.
Figure 3d presents an assembly of tomograms from islets
of different sizes and depths, illustrating the resolving
power of xfOCM.
Validation of xfOCM tomograms by immunohistochemistry
To ascertain that the spherical structures were indeed islets,
we sectioned a subset of the samples. Figure 4 shows
alignments between immunostained sections and virtual
sections through an xfOCM stack. Cryosections were
immunolabelled to identify beta cells (using anti-insulin
antibody), ducts (using anti-DBA-lectin antibody) and
blood vessels (using anti-platelet/endothelial cell adhesion
molecule-1 [PECAM] antibody). Overlays showed good
correspondence between the cryosections and the virtual
sections from the xfOCM data (Fig. 4). The few unmatched
differences result from the distortions that tissues undergo
during fixation and cryosectioning, and were compensated
by a slight scaling of the xfOCM data. This demonstrates
the advantage of imaging the tissue structure in fresh,
unfixed tissue, where the native tissue morphology is
revealed. This benefit has also been stressed in the context
of other in vivo imaging studies [23].
Imaging of mice injected with streptozotocin To determine
whether xfOCM could detect changes in beta cell mass, we
injected a group of mice (n=7) with streptozotocin, a drug
which selectively kills insulin-producing cells [24]. A
control group (n=6) was injected with the citrate buffer
that served as the vehicle for the drug. Four to 7 days after
injection all control mice showed normal levels of blood
glucose (8.6±1 mmol/l, n=6) and total insulin content
(58.8±15.4 μg per pancreas, n=6) (Fig. 5a, f). In contrast,
the mice that had received streptozotocin showed markedly
increased (p<0.002) blood glucose levels (25.47±
3.27 mmol/l, n=7) and a significantly lower (p<0.001)
total insulin content (25.9±15.6 μg per pancreas, n=7)
(Fig. 5a, f).
The xfOCM analysis of the samples, carried out under
double-blind conditions, showed that some of the pancreases
contained numerous islets whereas others contained signifi-
cantly fewer islets (p<0.001; Fig. 5b). Opening of the codes
revealed that all of the pancreases of the former type were
from control mice with normal glucose homeostasis, whereas
all the samples of the latter type suffered from hyper-
glycaemia resulting from streptozotocin injection.
The few islets remaining after streptozotocin treatment
were of various sizes without privileged volume category.
(Fig. 5g). Mean values for contrast and islet homogeneity
were significantly different from the corresponding values
for the control islets (p<0.001) (Fig. 5c, h) when only islets
larger than 1,000 μm3 were included. Figure 5d, e, i, j
shows two selected islets of approximately the same size
and depth in the tissue, indicating the difference in
homogeneity of control and treated islets. These experi-
ments demonstrate that xfOCM can detect beta cell loss and
alterations in streptozotocin-treated animals.
Imaging of pancreas in vivo Finally, we scanned the head of
the pancreas in vivo after laparotomy of anaesthetised mice.
To increase the scanning speed, small regions of 256×256
pixels were scanned with low sampling in less than 5 s. The
few remaining movement artefacts were corrected with an
image registration algorithm [25]. After imaging, the incision
was sutured allowing the mouse to recover.
Fig. 4 a Three-dimensionally rendered volume (0.86×1.7×0.78 mm)
of the pancreas head. b Virtual section of the tomographic data.
c Cryosection of the same area, immunohistochemically labelled for
insulin (red), platelet/endothelial cell adhesion molecule-1 (PECAM-
1) (green) and DBA lectin (blue). d Overlay of cryosection with
xfOCM data identifying the islets and vessel structures. Identical scale
bar of 250 μm for b, c and d
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An overview of samples measured in vivo is shown in
Fig. 6. With the three-dimensional data it is possible to
derive the shape of the islets and their position relative to
ducts, blood vessels and pancreatic lobes (Fig. 6d and ESM
videos 4 and 5). The semi-automatically detected islets
were analysed and revealed a stronger absorption of tissue
in the living organism, limiting the imaging depth to about
300 μm, as indicated in Fig. 6f.
Discussion
In this study, we first characterised the imaging capacity of
xfOCM by measuring fixed and excised pancreatic tissue.
Comparison with histology confirmed that xfOCM can
detect islets of all sizes and their association with ducts and
blood vessels. Next, we found that xfOCM can discriminate
between the islets of animals that had normal insulin
content from the mice suffering from hyperglycaemia and
decreased insulin content as a result of the beta cell death
induced by streptozotocin. The data show that xfOCM can
detect changes in the number of islets and in the contrast
and homogeneity of the few residual islets that survive the
cytotoxic effect of the drug. Measurements made from
living mice showed that xfOCM can visualise pancreatic
lobules, ducts, blood vessel networks and islets of Langer-
hans in vivo.
OCT is a well established clinical technique in oph-
thalmology for retinal imaging and is gaining importance
for minimally invasive imaging of other biological tissues.
OCT has been reported in an earlier work to image fixed
pancreatic tissue and detect islets [26]. However, only the
high, near isotropic, resolution of xfOCM in combination
with the in-parallel depth extraction giving high-speed
imaging allows in vivo imaging and generates tomograms
exhibiting high contrast. This contrast is generated by an
intrinsic sample property without any exogenous labelling.
Hence, individual islets were visualised in the living
organism as well as in fixed tissue. The exact nature of
the strong scattering of the islets remains unclear. Whether
it is the whole structure of the beta cell that strongly scatters
the light, as indicated by the streptozotocin experiments, or
only the insulin-containing vesicles within the beta cells has
to be shown by further experiments.
A recently published work [27] shows a procedure for
imaging the pancreas in vivo with two-photon microscopy
and involves gluing the pancreas between two glass plates.
In contrast, once the pancreas is exposed, xfOCM works
contact free without immersion or coverslips and requires
only slight stabilisation of the sample to suppress the
breathing motion of several millimetres. Repeated measure-
ments should be feasible, providing that the same area of the
pancreas can be identified sequentially. For such longitudinal
studies, the access to the pancreas could be simplified by
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Fig. 5 Exposure of C57B6 mice to streptozotocin (grey bars) resulted
in a marked increase in blood glucose levels (a) and in a parallel
decrease in the insulin content of the pancreas (f) compared with the
control group (white bars). The selective beta cell death induced by
the drug also decreased the number of islets found in the analysed
regions of interest (b, screened tissue volume of 2.5 mm2 per animal).
g The logarithmic distribution of the islet size exhibits a characteristic
pattern for the control islets that is lost in the case of the remaining
islets of treated animals. The few remaining islets (only islets
>1000 μm3 taken into account) likewise show a reduced contrast (c)
and homogeneity (h). (a, b, c, f and h show means ± SE, ***p<
0.001). Results from control mice are shown by the white bars and
results for the treated mice are shown in grey. An islet surviving in a
diabetic mouse (e, j) shows a significant reduction in contrast, compared
to a control islet (d, i). The columns show en-face views (d, e) and lateral
scans (i, j), averaged over the 20 slides indicated by the white lines. The
lateral scans are adjusted in their axial position to show identical sample
depths. The scale bar shows 100 μm and applies to all tomograms
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employing an endoscope or a glass window in the abdominal
wall, making our method minimally invasive.
With the three-dimensional volumetric data at hand,
quantitative measurements of islet volume, shape and signal
strength were possible in a semi-automatic way. This
analysis enabled the detection of subtle islet alterations,
and provided islet size distributions. The well-known
exponential distribution of islet sizes [e.g. 7] was not
matched here, because only a limited amount of the whole
islet population was assessed. However, judging from the
diameter of the smallest islets detected (15 μm), the
resolution of xfOCM is one order of magnitude higher
than that of OPT [7].
Furthermore, the quantitative analysis estimated the
imaging depth, which was more limited in living than in
fixed samples. The depths achieved are comparable with
those reported for two-photon microscopy. A trade-off
between a light source in a longer wavelength region and
the resulting reduced axial resolution could further optimise
imaging performance. Even then, it is unlikely that xfOCM
could measure the whole volume of the pancreas. Still, the
surface volume of the pancreas is screened with unprece-
dented accuracy, offering new insight into this organ.
Essentially, with xfOCM the islets are studied in their
natural environment, and disease evolution and islet destiny
can be evaluated. This is in contrast to the anterior eye
chamber imaging platform [12] that is limited to the study
of the engraftment process and graft function in an
immunologically privileged engraftment site. Although
lacking molecular specificity, xfOCM is potentially able
to measure islets in any site accessible to the microscope,
provided the islets contrast with the surrounding tissue.
Also, xfOCM could be combined with two-photon micros-
copy to provide the scattering and fluorescence signal in
parallel.
The newest generation of line cameras further increase
the imaging speed of xfOCM and will enable the
monitoring of islets in real time to study the response to
stimuli or drug administration. This increased speed will
also enhance the capacity of OCT to perform Doppler flow
measurements, a technique we and others have previously
used in the eye [28, 29]. This principle could be adapted to
reveal the pancreatic blood flow and provide additional
functional variables. The sensitivity of xfOCM should
prove useful to monitor changes in beta cell number—for
example, during islet regeneration [30] or upon islet
transplantation to visualise the islets and their vascularisa-
tion in the recipient. Analysing dispersion and spectral
absorption characteristics in the sample could add further
functional contrast such as variations in metabolite concen-
trations [31, 32]. Eventually, xfOCM could help design new
PET and MRI probes that selectively label the pancreatic beta
cells and that are necessary for clinical imaging of pancreatic
islets by these techniques. Adding a contrast agent for xfOCM
to prospective probes would enable the monitoring of their
dynamics and specificity on a microscopic scale.
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Fig. 6 In vivo imaging of islets. a Side view and (b, c, d)
corresponding en-face views (indicated by the white lines in the side
view, median value over five slices) at different depths, showing islets
and a duct- or vessel-like structure. The scale bars show 100 μm and
apply to all views. e Three-dimensional rendering of a similar in vivo
tomogram showing several islets at various depths, contained in a lobe
of a pancreas. The volume measures 1 mm×1 mm in the lateral
directions and 500 μm in the vertical axis. f The depth distribution of
the islets detected in vivo (six animals, 123 islets)
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